Stock Code: 002038 Stock Abbreviation: Shuanglu Pharmaceutical Announcement No.: 2026-010
Beijing Shuanglu Pharmaceutical Co., Ltd.
Notice on Holding the 2025 Annual Report Online Performance Briefing
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed in this announcement, and that there are no false records, misleading statements, or significant omissions.
Beijing Shuanglu Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") disclosed the "2025 Annual Report" and the "2025 Annual Report Summary" on April 29, 2026. To establish a good communication mechanism with investors and enable investors to further understand the Company's financial status, operating conditions, and future development plans, the Company will hold the 2025 Annual Performance Briefing online via the All-Round Network platform from 15:00 to 17:00 on May 15, 2026 (Friday). Investors can log in to the All-Round Network "Investor Relations Interactive Platform" (https://ir.p5w.net/zj/) to participate in this annual performance briefing online.
The attendees of this online performance briefing will include: Mr. Xu Mingbo, Chairman and General Manager of the Company; Ms. Qian Lingjia and Ms. Cheng Longyun, Independent Directors; Ms. Liang Shujie, Director and Secretary of the Board; and Ms. Ji Li, Financial Controller.
To fully respect investors and enhance the relevance of communication, we are soliciting questions from investors in advance for the Company's 2025 Annual Performance Briefing to widely gather investors' opinions and suggestions. Investors can visit https://ir.p5w.net/zj/ or scan the QR code below before May 14, 2026, to enter the dedicated page for question collection and submit their questions. We kindly request investors to submit their questions of concern through the All-Round Network system, which will facilitate the Company's response to investors' common concerns during the performance briefing and enhance the relevance of this briefing. During the exchange of this event, investors can still log in to the event interface for interactive questions.